Large-scale sequence analysis of M gene of influenza A viruses from different species: Mechanisms for emergence and spread of amantadine resistance

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 10, 2009, Pages 4457-4463

  Furuse, Yuki ^a   Suzuki, Akira ^a   Oshitani, Hitoshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; M PROTEIN; PROTEIN M2;

ANTIVIRAL RESISTANCE; ARTICLE; DRUG MECHANISM; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC REASSORTMENT; HOST; HUMAN; INFLUENZA VIRUS; INFLUENZA VIRUS A; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS LOAD; VIRUS REPLICATION;

AMANTADINE; ANIMALS; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS; PHYLOGENY; VIRAL MATRIX PROTEINS;

EID: 70349323515     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00650-09     Document Type: Article

References (42)

1. Abed, Y., N. Goyette, and G. Boivin. 2005. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob. Agents Chemother. 49:556-559.
2. Anisimova, M., and O. Gascuel. 2006. Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative. Syst. Biol. 55:539-552.
3. Appleyard, G. 1977. Amantadine-resistance as a genetic marker for influenza viruses. J. Gen. Virol. 36:249-255.
4. Bao, Y., P. Bolotov, D. Dernovoy, B. Kiryutin, L. Zaslavsky, T. Tatusova, J. Ostell, and D. Lipman. 2008. The influenza virus resource at the National Center for Biotechnology Information. J. Virol. 82:596-601.
5. Bright, R. A., M.-J. Medina, X. Xu, G. Perez-Oronoz, T. R. Wallis, X. M. Davis, L. Povinelli, N. J. Cox, and A. I. Klimov. 2005. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366:1175-1181.
6. Campo, D. S., Z. Dimitrova, R. J. Mitchell, J. Lara, and Y. Khudyakov. 2008. Coordinated evolution of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 105:9685-9690.
7. Cheung, C.-L., J. M. Rayner, G. J. D. Smith, P. Wang, T. S. P. Naipospos, J. Zhang, K.-Y. Yuen, R. G. Webster, J. S. M. Peiris, Y. Guan, and H. Chen. 2006. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J. Infect. Dis. 193:1626-1629.
8. Felsenstein, J. 1981. Evolutionary trees from DNA sequences: a maximum likelihood approach. J. Mol. Evol. 17:368-376.
9. Furuse, Y., A. Suzuki, T. Kamigaki, and H. Oshitani. 2009. Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis. Virol. J. 6:67.
10. Furuse, Y., A. Suzuki, T. Kamigaki, M. Shimizu, N. Fuji, and H. Oshitani. 2008. Reversion of Influenza A (H3N2) from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J. Clin. Microbiol. 47:841-844.
11. Hauge, S. H., S. Dudman, K. Borgen, A. Lackenby, and O. Hungnes. 2009. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg. Infect. Dis. 15:155-162.
12. Hay, A. J., A. J. Wolstenholme, J. J. Skehel, and M. H. Smith. 1985. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4:3021-3024.
13. Hayden, F. G., and A. J. Hay. 1992. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr.t Top. Microbiolo. Immunol. 176:119-130.
14. Hayden, F. G., S. J. Sperber, R. B. Belshe, R. D. Clover, A. J. Hay, and S. Pyke. 1991. Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob. Agents Chemother. 35:1741-1747.
15. He, G., J. Qiao, C. Dong, C. He, L. Zhao, and Y. Tian. 2008. Amantadine resistance among H5N1 avian influenza viruses isolated in Northern China. Antivir. Res. 77:72-76.
16. Hill, A. W., R. P. Guralnick, M. J. Wilson, F. Habib, and D. Janies. 2008. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza. Infect. Genet. Evol. 9:169-178.
17. Ilyushina, N. A., E. A. Govorkova, and R. G. Webster. 2005. Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia. Virology 341:102-106.
18. Kimura, M. 1968. Evolutionary rate at the molecular level. Nature 217: 624-626.
19. Kosakovsky Pond, S. L., and S. D. W. Frost. 2005. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol. Biol. Evol. 22:1208-1222.
20. Kramarz, P., D. Monnet, A. Nicoll, C. Yilmaz, and B. Ciancio. 2009. Use of oseltamivir in 12 European countries between 2002 and 2007 - lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses. Euro Surveill. 14:19112.
21. Kumar, S., M. Nei, J. Dudley, and K. Tamura. 2008. MEGA: a biologistcentric software for evolutionary analysis of DNA and protein sequences. Brief.n Bioinform. 9:299-306. (Pubitemid 351890826)
22. Lackenby, A., C. I. Thompson, and J. Democratis. 2008. The potential impact of neuraminidase inhibitor resistant influenza. Curr. Opin. Infect. Dis. 21:626-638.
23. Lamb, R. A., C. J. Lai, and P. W. Choppin. 1981. Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc. Natl. Acad. Sci. USA 78:4170-4174.
24. Lanave, C., G. Preparata, C. Saccone, and G. Serio. 1984. A new method for calculating evolutionary substitution rates. J. Mol. Evol. 20:86-93.
25. Maugh, T. H. 1976. Amantadine: an alternative for prevention of influenza. Science 192:130-131.
26. Ohta, T., and J. H. Gillespie. 1996. Development of neutral and nearly neutral theories. Theor. Popul. Biol. 49:128-142.
27. Pinto, L. H., L. J. Holsinger, and R. A. Lamb. 1992. Influenza virus M2 protein has ion channel activity. Cell 69:517-528.
28. Pond, S. L. K., S. D. W. Frost, Z. Grossman, M. B. Gravenor, D. D. Richman, and A. J. L. Brown. 2006. Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput. Biol. 2:e62.
29. Pond, S. L. K., S. D. W. Frost, and S. V. Muse. 2005. HyPhy: hypothesis testing using phylogenies. Bioinformatics 21:676-679.
30. Regoes, R. R., and S. Bonhoeffer. 2006. Emergence of drug-resistant influenza virus: population dynamical considerations. Science 312:389-391.
31. Saito, R., Y. Suzuki, D. Li, H. Zaraket, I. Sato, H. Masaki, T. Kawashima, S. Hibi, Y. Sano, Y. Shobugawa, T. Oguma, and H. Suzuki. 2008. Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan. J. Infect. Dis. 197:630-632. (Author's reply, 197:632-633.)
32. Schmidtke, M., R. Zell, K. Bauer, A. Krumbholz, C. Schrader, J. Suess, and P. Wutzler. 2006. Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001. Intervirology 49:286-293. (Pubitemid 44238845)
33. Sergei, L., A. F. Y. P. Kosakovsky Pond, and S. D. W. Frost. 2007. Estimating selection pressures on alignments of coding sequences analyses using HyPhy. http://www.hyphy.org/pubs/hyphybook2007.pdf.
34. Shiraishi, K., K. Mitamura, Y. Sakai-Tagawa, H. Goto, N. Sugaya, and Y. Kawaoka. 2003. High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. J. Infect. Dis. 188:57-61.
35. Simonsen, L., C. Viboud, B. T. Grenfell, J. Dushoff, L. Jennings, M. Smit, C. Macken, M. Hata, J. Gog, M. A. Miller, and E. C. Holmes. 2007. The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol. Biol. Evol. 24:1811-1820.
36. Sipress, A. 1 November 2005, posting date. Bird flu drug rendered useless. Washington Post Foreign Service http://www.washingtonpost.com/wp-dyn/ content/article/2005/06/17/AR2005061701214.html.
37. Stamatakis, A., P. Hoover, and J. Rougemont. 2008. A rapid bootstrap algorithm for the RAxML Web servers. Syst. Biol. 57:758-771.
38. Stamatakis, A. P., T. Ludwig, and H. Meier. 1 November 2008, posting date. Computing large phylogenies with statistical methods: problems and solutions. icwww.epfl.ch/~stamatak/index-Dateien/publications/BGRS2004.PDF.
39. Suzuki, Y. 2006. Natural selection on the influenza virus genome. Mol. Biol. Evol. 23:1902-1911.
40. Suzuki, Y., and T. Gojobori. 1999. A method for detecting positive selection at single amino acid sites. Mol. Biol. Evol. 16:1315-1328.
41. Wang, C., K. Takeuchi, L. H. Pinto, and R. A. Lamb. 1993. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J. Virol. 67:5585-5594. (Pubitemid 23241395)
42. Webster, R. G., W. J. Bean, O. T. Gorman, T. M. Chambers, and Y. Kawaoka. 1992. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56:152-179.